RANIBIZUMAB-NUNA: 36 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
36
Total FAERS Reports
8 (22.2%)
Deaths Reported
4
Hospitalizations
36
As Primary/Secondary Suspect
2
Disabilities
Prescription
Status
FDA Application: 761202 ·
First Report: 20221213 · Latest Report: 20250625
What Are the Most Common RANIBIZUMAB-NUNA Side Effects?
#1 Most Reported
Death
7 reports (19.4%)
#2 Most Reported
Hypersensitivity
3 reports (8.3%)
#3 Most Reported
Eye haemorrhage
3 reports (8.3%)
All RANIBIZUMAB-NUNA Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 7 | 19.4% | 7 | 0 |
Who Reports RANIBIZUMAB-NUNA Side Effects? Age & Gender Data
Gender: 63.2% female, 36.8% male. Average age: 71.1 years. Most reports from: CA. View detailed demographics →
Is RANIBIZUMAB-NUNA Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2022 | 1 | 0 | 0 |
| 2023 | 4 | 2 | 0 |
| 2024 | 9 | 0 | 1 |
| 2025 | 5 | 1 | 1 |
What Is RANIBIZUMAB-NUNA Used For?
| Indication | Reports |
|---|---|
| Neovascular age-related macular degeneration | 13 |
| Product used for unknown indication | 9 |
| Retinal vein occlusion | 5 |
Official FDA Label for RANIBIZUMAB-NUNA
Official prescribing information from the FDA-approved drug label.